HDAC9 and HIV-1 infection: As a positive control, we used a potent inhibitor of histone deacetylases (HDAC), suberoylanilide hydroxamic acid (SAHA) [35] which was recently used in preclinical trials to eliminate latent HIV-1 infection [36].